Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4366 to 4380 of 7679 results

  1. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/7 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

    Research recommendation
    Published
    10 February 2020

  2. Children and young people aged 5 to 18 years – brief, group-based, ADHDfocused, parent-training intervention What is the clinical and cost effectiveness, and optimum length, of a brief parent-training intervention for parents and carers of children and young people with attention deficit hyperactivity disorder (ADHD) aged 5 to 18 years?

    Recommendation ID NG87/1 Question Children and young people aged 5 to 18 years – brief, group-based, ADHDfocused, parent-training intervention What

    Research recommendation
    Published
    14 November 2018

  3. Children and young people in transition between settings:- What is the effect of specific interventions to support children and young people during transition between inpatient mental health settings and community or care home settings? Is there any particular benefit for black, Asian and minority ethnic communities?

    Recommendation ID NG53/3 Question Children and young people in transition between settings:- What is the effect of specific interventions

    Research recommendation
    Published
    17 October 2016

  4. Chronic conditions:- What is the prevalence of disease in the UK prison population?

    Recommendation ID NG57/2 Question Chronic conditions:- What is the prevalence of disease in the UK prison population? Any explanatory

    Research recommendation
    Published
    16 November 2017

  5. For children and young people with intractable cancer-related pain and pain associated with specific diseases (such as epidermolysis bullosa), what is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on to standard treatment to improve symptoms compared with treatment with standard care?

    Recommendation ID NG144/2 Question For children and young people with intractable cancer-related pain and pain associated with specific

    Research recommendation
    Published
    10 February 2020

  6. Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what is the overall effect on people's health?

    Recommendation ID NG70/3 Question Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what

    Research recommendation
    Published
    12 October 2018

  7. Clinical predictors of non-IgE-mediated food allergy:- Which features in the clinical history best predict the presence of non-IgEmediated food allergy in children and young people in primary care and community settings?

    Recommendation ID CG116/2 Question Clinical predictors of non-IgE-mediated food allergy:- Which features in the clinical history best predict

    Research recommendation
    Published
    9 June 2015

  8. Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary syndromes (ACS).

    Recommendation ID TA236/1 Question Clinical trials should be conducted comparing ticagrelor with prasugrel in people with acute coronary

    Research recommendation
    Published
    9 June 2015

  9. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG581/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  10. Clinicians should enter details about all patients having selective internal radiation therapy (SIRT) for unresectable primary intrahepatic cholangiocarcinoma onto a suitable registry.

    Recommendation ID IPG630/2 Question Clinicians should enter details about all patients having selective internal radiation therapy (SIRT)

    Research recommendation
    Published
    18 December 2018

  11. Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life outcomes using validated scales. NICE may update the guidance on publication of further evidence into infracoccygeal sacropexy using mesh to repair uterine prolapse.

    Recommendation ID IPG582/1 Question Clinicians are encouraged to collect long-term data on clinical outcomes and patient-reported quality-of-life

    Research recommendation
    Published
    12 October 2018

  12. Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated or triclosan-impregnated sutures?

    Recommendation ID NG125/5 Question Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated

    Research recommendation
    Published
    16 August 2019

  13. Clinicians should collect data on all patients undergoing focal cryoablation (including details of case selection, methods of follow-up and outcomes) for local audit. Clinicians should enter details about all patients undergoing focal therapy using cryoablation for localised prostate cancer onto the European Registry for Cryosurgical Ablation of the Prostate (EuCAP) register and review clinical outcomes locally.

    Recommendation ID IPG423/2 Question Clinicians should collect data on all patients undergoing focal cryoablation (including details of

    Research recommendation
    Published
    9 June 2015

  14. What is the impact of coexisting physical health conditions on the mortality of people with complex psychosis?

    Recommendation ID NG181/8 Question What is the impact of coexisting physical health conditions on the mortality of people with complex

    Research recommendation
    Published
    26 October 2020

  15. Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with motor neurone disease (MND) on clinical practice, the person and their family and carers? Does repeated assessment provide more benefit than assessment at a single point at diagnosis?

    Recommendation ID NG42/2 Question Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with

    Research recommendation
    Published
    21 March 2016